Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 343

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Management of the irritable bowel syndrome

Camilleri, Michael·2001·Gastroenterology
DOI 10.1053/gast.2001.21908
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/gast.2001.21908

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 158

  1. Drossman, 1999, Rome II: a multinational consensus document on functional gastrointestinal disorders, Gut, 45, 1
  2. Kruis, 1984, A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease, Gastroenterology, 87, 1, 10.1016/0016-5085(84)90119-7 · DOI
  3. Vanner, 1999, Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome, Am J Gastroenterol, 94, 2912, 10.1111/j.1572-0241.1999.01437.x · DOI
  4. Manning, 1978, Towards a positive diagnosis of the irritable bowel, BMJ, 2, 653, 10.1136/bmj.2.6138.653 · DOI · Paper page
  5. Thompson, 1989, Irritable bowel syndrome: guidelines for the diagnosis, Gastroenterol Int, 2, 92
  6. Camilleri, 1992, The irritable bowel syndrome: mechanisms and a practical approach to management, Ann Intern Med, 116, 1001, 10.7326/0003-4819-116-12-1001 · DOI
  7. Drossman, 1997, Irritable bowel syndrome: a technical review for practice guideline development, Gastroenterology, 112, 2120, 10.1053/gast.1997.v112.agast972120 · DOI · Paper page
  8. Camilleri, 1997, Review article: irritable bowel syndrome, Aliment Pharmacol Ther, 11, 3, 10.1046/j.1365-2036.1997.84256000.x · DOI · Paper page
  9. Saito, 2000, The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates (abstr), Gastroen-terology, 118, A396, 10.1016/S0016-5085(00)83693-8 · DOI
  10. Sandler, 1990, Epidemiology of irritable bowel syndrome in the United States, Gastroenterology, 99, 409, 10.1016/0016-5085(90)91023-Y · DOI
  11. Locke, 1999, The incidence of clinically diagnosed irritable bowel syndrome in the community (abstr), Gastroenterology, 116, A76
  12. Talley, 1992, Prevalence of gastrointestinal symptoms in the elderly: a population-based study, Gastroenterology, 102, 895, 10.1016/0016-5085(92)90175-X · DOI
  13. Chaudhary, 1962, The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases, Q J Med, 31, 307
  14. Choi, 1997, A pilot study of motility and tone of the left colon in diarrhea due to functional disorders and dysautonomia, Am J Gastroenterol, 92, 297
  15. Bazzocchi, 1991, Effect of eating on colonic motility and transit in patients with functional diarrhea. Simultaneous scintigraphic and manometric evaluations, Gastroenterology, 101, 1298, 10.1016/0016-5085(91)90080-5 · DOI
  16. Locke, 2000, Risk factors for irritable bowel syndrome: role of analgesics and fool sensitivities, Am J Gastroenterol, 95, 157, 10.1111/j.1572-0241.2000.01678.x · DOI
  17. Dainese, 1999, Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients, Am J Gastroenterol, 94, 1892, 10.1111/j.1572-0241.1999.01226.x · DOI
  18. Bearcroft, 1998, Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study, Gut, 42, 42, 10.1136/gut.42.1.42 · DOI
  19. Ragnarsson, 1998, Pain is temporally related to eating but not to defecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study, Eur J Gastroenterol Hepatol, 10, 415, 10.1097/00042737-199805000-00011 · DOI
  20. Fullerton, 1998, Functional digestive disorders (FDD) in the year 2000–economic impact, Eur J Surg, 582, 62
  21. Camilleri, 2000, Economic burden of irritable bowel syndrome reappraised with strategies to control expenditures, Pharmacoeconomics, 4, 331, 10.2165/00019053-200017040-00003 · DOI
  22. Stewart, 1999, Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features, Am J Gastroenterol, 94, 3530, 10.1111/j.1572-0241.1999.01642.x · DOI · Paper page
  23. Hahn, 1997, Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life, Aliment Pharmacol Ther, 11, 553, 10.1046/j.1365-2036.1997.00160.x · DOI
  24. Hahn, 1999, Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom, Digestion, 60, 77, 10.1159/000007593 · DOI
  25. Wells, 1997, Clinical economics review: irritable bowel syndrome, Aliment Pharmacol Ther, 11, 1019, 10.1046/j.1365-2036.1997.00262.x · DOI
  26. Karampela, 1999, Costs associated with healthcare resource use and productivity loss in patients with irritable bowel syndrome (IBS) (abstr), Gastroenterology, 116, A69
  27. Longstreth, 1997, Irritable bowel syndrome. Diagnosis in the managed care era, Dig Dis Sci, 42, 1105, 10.1023/A:1018864915375 · DOI
  28. Everhart, 1991, Irritable bowel syndrome in office-based practice in the United States, Gastroenterology, 100, 998, 10.1016/0016-5085(91)90275-P · DOI
  29. Mitchell, 1987, Survey of the AGA membership relating to patients with functional gastrointestinal disorders (letter), Gastroenterology, 92, 1282, 10.1016/S0016-5085(87)91099-7 · DOI · Paper page
  30. Camilleri, 1989, Motility disorders and stress: significance to the irritable bowel syndrome, Dig Dis Sci, 34, 1777, 10.1007/BF01540058 · DOI
  31. Almy, 1947, Alterations in man under stress. Experimental production of changes simulating the “irritable colon”, Gastroenterology, 8, 616
  32. Bazzocchi, 1990, Postprandial colonic transit and motor activity in chronic constipation, Gastroenterology, 98, 686, 10.1016/0016-5085(90)90289-D · DOI
  33. Cann, 1983, Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns, Gut, 24, 405, 10.1136/gut.24.5.405 · DOI
  34. Vassallo, 1992, Transit through the proximal colon influences stool weight in the irritable bowel syndrome, Gastroenterology, 102, 102, 10.1016/0016-5085(92)91789-7 · DOI
  35. Stivland, 1991, Scintigraphic measurement of regional gut transit in idiopathic constipation, Gastroenterology, 101, 107, 10.1016/0016-5085(91)90466-X · DOI · Paper page
  36. Hammer, 1993, Effect of a 5-HT3 antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome, Aliment Pharm Ther, 7, 543, 10.1111/j.1365-2036.1993.tb00131.x · DOI
  37. Prior, 1990, Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects, Gut, 31, 458, 10.1136/gut.31.4.458 · DOI
  38. Vassallo, 1992, Colonic tone and motility in patients with irritable bowel syndrome, Mayo Clin Proc, 67, 725, 10.1016/S0025-6196(12)60796-4 · DOI
  39. Kellow, 1987, Altered small bowel motility in irritable bowel syndrome is correlated with symptoms, Gastroenterology, 92, 1885, 10.1016/0016-5085(87)90620-2 · DOI · Paper page
  40. Gorard, 1994, Ambulatory small intestinal motility in diarrhoea predominant irritable bowel syndrome, Gut, 35, 203, 10.1136/gut.35.2.203 · DOI
  41. Schmidt, 1996, Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome, Scand J Gastroenterol, 31, 581, 10.3109/00365529609009131 · DOI
  42. Evans, 1996, Jejunal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features, Gastroenterology, 110, 393, 10.1053/gast.1996.v110.pm8566585 · DOI
  43. Camilleri, 1992, Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders, Gastroenterology, 103, 36, 10.1016/0016-5085(92)91092-I · DOI
  44. Charles, 1995, Scintigraphy of the whole gut: clinical evaluation of transit disorders, Mayo Clin Proc, 70, 113, 10.4065/70.2.113 · DOI
  45. Charles, 1997, Rapid gastric emptying in patients with functional diarrhea, Mayo Clin Proc, 72, 323, 10.4065/72.4.323 · DOI
  46. Ritchie, 1973, Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome, Gut, 14, 125, 10.1136/gut.14.2.125 · DOI · Paper page
  47. Prior, 1990, Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects, Gut, 31, 458, 10.1136/gut.31.4.458 · DOI
  48. Mertz, 1995, Altered rectal perception is a biological marker of patients with irritable bowel syndrome, Gastroenterology, 109, 40, 10.1016/0016-5085(95)90267-8 · DOI · Paper page
  49. Lembo, 1997, Sigmoid afferent mechanisms in patients with irritable bowel syndrome, Dig Dis Sci, 42, 1112, 10.1023/A:1018817132213 · DOI
  50. Schmulson, 2000, Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients, Am J Gastroenterol, 95, 152, 10.1111/j.1572-0241.2000.01677.x · DOI
  51. Cook, 1987, Patients with irritable bowel syndrome have greater pain tolerance than normal subjects, Gastroenterology, 93, 727, 10.1016/0016-5085(87)90434-3 · DOI
  52. Morris-Yates, 1998, Evidence of a genetic contribution to functional bowel disorder, Am J Gastroenterol, 93, 1311, 10.1111/j.1572-0241.1998.440_j.x · DOI
  53. Aggarwal, 1994, Predominant symptoms in irritable bowel correlate with specific autonomic nervous system abnormalities, Gastroenterology, 106, 945, 10.1016/0016-5085(94)90753-6 · DOI · Paper page
  54. Gwee, 1999, The role of psychological and biological factors in postinfective gut dysfunction, Gut, 44, 400, 10.1136/gut.44.3.400 · DOI · Paper page
  55. Gwee, 1996, Psychometric scores and persistence of irritable bowel after infectious diarrhea, Lancet, 347, 150, 10.1016/S0140-6736(96)90341-4 · DOI
  56. Thornley, 2000, Bacterial toxins influence long-term bowel dysfunction following campylobacter enteritis (abstr), Gastroenterology, 118, A702, 10.1016/S0016-5085(00)84940-9 · DOI
  57. Drossman, 1999, Mind over matter in the postinfective irritable bowel, Gut, 44, 306, 10.1136/gut.44.3.306 · DOI
  58. Rumessen, 1987, Malabsorption of fructose-sorbitol mixtures. Interactions causing abdominal distress, Scand J Gastroenterol, 22, 431, 10.3109/00365528708991486 · DOI
  59. Suarez, 1995, A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance, N Engl J Med, 333, 1, 10.1056/NEJM199507063330101 · DOI · Paper page
  60. Haderstorfer, 1989, Intestinal gas production from bacterial fermentation of undigested carbohydrate in irritable bowel syndrome, Am J Gastroenterol, 84, 375
  61. Chami, 1991, A simple radiologic method to estimate the quantity of bowel gas, Am J Gastroenterol, 86, 599
  62. Jones, 1982, Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome, Lancet, 2, 1115, 10.1016/S0140-6736(82)92782-9 · DOI · Paper page
  63. King, 1998, Abnormal colonic fermentation in irritable bowel syndrome, Lancet, 352, 1187, 10.1016/S0140-6736(98)02146-1 · DOI · Paper page
  64. Oddsson, 1978, A secretory epithelium of the small intestine with increased sensitivity to bile acids in irritable bowel syndrome associated with diarrhoea, Scand J Gastroenterol, 13, 409, 10.3109/00365527809181914 · DOI
  65. Serra, 1998, Intestinal gas dynamics and tolerance in humans, Gastroenterology, 115, 542, 10.1016/S0016-5085(98)70133-7 · DOI
  66. Serra, 2000, New insight on functional gut disease: is gas handling the answer? (abstr), Gastroenterology, 112, A822
  67. Caldarella, 2000, Stimulation of intestinal gas propulsion is the key to treat gas retention in functional patients (abstr), Gastroenterology, 118, A138, 10.1016/S0016-5085(00)82629-3 · DOI
  68. Lydiard, 1986, Can panic disorder present as irritable bowel syndrome?, J Clin Psychiatr, 47, 470
  69. Young, 1976, Psychiatric illness and the irritable bowel syndrome. Practical implications for the primary physician, Gastroenterology, 70, 162, 10.1016/S0016-5085(76)80002-9 · DOI · Paper page
  70. Whitehead, 1988, Role of psychologic symptoms in irritable bowel syndrome: comparison of community and clinic samples, Gastroenterology, 95, 709, 10.1016/S0016-5085(88)80018-0 · DOI · Paper page
  71. Drossman, 1995, Sexual and physical abuse and gastrointestinal illness, Ann Intern Med, 123, 782, 10.7326/0003-4819-123-10-199511150-00007 · DOI · Paper page
  72. Talley, 1994, Gastrointestinal tract symptoms and self-reported abuse: a population-based study, Gastroenterology, 107, 1040, 10.1016/0016-5085(94)90228-3 · DOI · Paper page
  73. Alpers, 2000, Why should psychotherapy be a useful approach to management of patients with non-ulcer dyspepsia? (editorial), Gastroenterology, 119, 869, 10.1053/gast.2000.17840 · DOI
  74. Klein, 1988, Controlled treatment trials in the irritable bowel syndrome: a critique, Gastroenterology, 95, 232, 10.1016/0016-5085(88)90319-8 · DOI
  75. Whitehead, 1988, Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples, Gastroenterology, 95, 709, 10.1016/S0016-5085(88)80018-0 · DOI · Paper page
  76. Drossman, 1995, Diagnosing and treating patients with refractory functional gastrointestinal disorders, Ann Intern Med, 123, 688, 10.7326/0003-4819-123-9-199511010-00008 · DOI
  77. Talley, 1992, Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders, Am J Epidemiology, 136, 165, 10.1093/oxfordjournals.aje.a116483 · DOI
  78. Harvey, 1987, Prognosis in the irritable bowel syndrome: a 5-year prospective study, Lancet, 1, 963, 10.1016/S0140-6736(87)90304-7 · DOI
  79. Francis, 1996, Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome?, Am J Gastroenterol, 91, 1348
  80. MacIntosh, 1992, Is rectal biopsy necessary in irritable bowel syndrome?, Am J Gastroenterol, 87, 1407
  81. Winawer, 1995, Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer, Bull World Health Organ, 73, 7
  82. Winawer, 1997, Colorectal cancer screening: clinical guidelines and rationale, Gastroenterology, 112, 594, 10.1053/gast.1997.v112.agast970594 · DOI · Paper page
  83. Bond, 1999, Screening guidelines for colorectal cancer, Am J Med, 106, 7S, 10.1016/S0002-9343(98)00339-8 · DOI
  84. Camilleri, 1994, Clinical management of intractable constipation, Ann Intern Med, 121, 520, 10.7326/0003-4819-121-7-199410010-00008 · DOI
  85. Clouse, 1994, Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience, Aliment Pharmacol Ther, 8, 409, 10.1111/j.1365-2036.1994.tb00308.x · DOI
  86. Cann, 1984, What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?, Gut, 25, 168, 10.1136/gut.25.2.168 · DOI
  87. Jarrett, 1994, Comparison of diet composition in women with and without functional bowel disorder, Gastroenterol Nurs, 6, 253, 10.1097/00001610-199406000-00004 · DOI
  88. Distrutti, 1999, Gastric wall tension determines perception of gastric distention, Gastroenterology, 116, 1035, 10.1016/S0016-5085(99)70006-5 · DOI
  89. Thumshirn, 1999, Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans, Gastroenterology, 116, 573, 10.1016/S0016-5085(99)70179-4 · DOI
  90. Malcolm, 1997, Pharmacological modulation of rectal tone alters perception of distention in humans, Am J Gastroenterol, 92, 2073
  91. Mueller-Lissner, 1988, Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta-analysis, BMJ, 296, 615, 10.1136/bmj.296.6622.615 · DOI
  92. Cook, 1990, Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome, Gastroenterology, 98, 66, 10.1016/0016-5085(90)91292-E · DOI
  93. Feldman, 1985, The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent abdominal pain: results in a prospective, double-blind, randomized, controlled trial, Am J Dis Child, 138, 1216, 10.1001/archpedi.1985.02140140050025 · DOI
  94. Arffmann, 1985, The effect of coarse wheat bran in the irritable bowel syndrome. A double-blind, cross-over study, Scand J Gastroenterol, 20, 295, 10.3109/00365528509091653 · DOI
  95. Lucey, 1987, Is bran efficacious in irritable bowel syndrome? A double-blind, placebo-controlled crossover study, Gut, 28, 221, 10.1136/gut.28.2.221 · DOI
  96. Kumar, 1987, Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight, Gut, 28, 150, 10.1136/gut.28.2.150 · DOI
  97. Snook, 1994, Bran supplementation in the treatment of irritable bowel syndrome, Aliment Pharmacol Ther, 8, 511, 10.1111/j.1365-2036.1994.tb00323.x · DOI
  98. Francis, 1994, Bran and irritable bowel syndrome: time for reappraisal, Lancet, 344, 39, 10.1016/S0140-6736(94)91055-3 · DOI
  99. Whitehead, 1990, Tolerance for rectosigmoid distention in irritable bowel syndrome, Gastroenterology, 98, 1187, 10.1016/0016-5085(90)90332-U · DOI · Paper page
  100. Haderstorfer, 1989, Intestinal gas production from bacterial fermentation of undigested carbohydrate in irritable bowel syndrome, Am J Gastroenterol, 84, 375
  101. Lasser, 1975, The role of intestinal gas in functional abdominal pain, N Engl J Med, 293, 524, 10.1056/NEJM197509112931103 · DOI
  102. Hebden, 1999, Impaired ascending colon clearance in response to rapid small bowel transit in bloated irritable bowel syndrome: bran exaggerates the problems (abstr), Gastroenterology, 116, A1004
  103. Voderholzer, 1997, Clinical response to dietary fiber treatment of chronic constipation, Am J Gastroenterol, 92, 95
  104. Hillman, 1984, Irritable bowel patients and their long-term response to a high fiber diet, Am J Gastroenterol, 79, 1
  105. Cann, 1984, Role of loperamide and placebo in management of irritable bowel syndrome, Dig Dis Sci, 29, 239, 10.1007/BF01296258 · DOI
  106. Read, 1982, Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency, Dig Dis Sci, 27, 807, 10.1007/BF01391374 · DOI · Paper page
  107. Efskind, 1996, A double-blind, placebo-controlled trial with loperamide in irritable bowel syndrome, Scand J Gastroenterol, 31, 463, 10.3109/00365529609006766 · DOI
  108. Hovdenak, 1987, Loperamide treatment of the irritable bowel syndrome, Scand J Gastroenterol, 130, 81, 10.3109/00365528709091004 · DOI
  109. Thaysen, 1976, Idiopathic bile salt catharsis, Gut, 17, 965, 10.1136/gut.17.12.965 · DOI
  110. Luman, 1995, Idiopathic bile acid malabsorption: long-term outcome, Eur J Gastroenterol Hepatol, 7, 641
  111. Brydon, 1996, Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea, Eur J Gastroenterol Hepatol, 8, 117, 10.1097/00042737-199602000-00005 · DOI
  112. Sciarretta, 1987, 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit, Gut, 28, 970, 10.1136/gut.28.8.970 · DOI
  113. Poynard, 1994, Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome, Aliment Pharmacol Ther, 8, 499, 10.1111/j.1365-2036.1994.tb00322.x · DOI
  114. Clouse, 1994, Antidepressants for functional gastrointestinal syndromes, Dig Dis Sci, 39, 2352, 10.1007/BF02087651 · DOI
  115. Heefner, 1978, Irritable colon and depression, Psychosomatics, 19, 540, 10.1016/S0033-3182(78)70930-8 · DOI
  116. Hislop, 1971, Psychological significance of the irritable colon syndrome, Gut, 12, 452, 10.1136/gut.12.6.452 · DOI
  117. Lancaster-Smith, 1982, Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity, Acta Psychiatr Scand, 66, 33, 10.1111/j.1600-0447.1982.tb00912.x · DOI
  118. Gorelick, 1998, Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans, Am J Physiol, 275, G460
  119. Myren, 1982, The effect of trimipramine in patients with the irritable bowel syndrome, Scand J Gastroenterol, 17, 871, 10.3109/00365528209181108 · DOI
  120. Myren, 1984, A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome, Scand J Gastroenterol, 19, 835, 10.1080/00365521.1984.12005817 · DOI
  121. Greenbaum, 1987, The effects of desipramine on IBS compared with atropine and placebo, Dig Dis Sci, 32, 257, 10.1007/BF01297051 · DOI
  122. Ritchie, 1980, Comparison of various treatments for irritable bowel syndrome, Br Med J, 281, 1317, 10.1136/bmj.281.6251.1317 · DOI
  123. Gram, 1994, Fluoxetine, N Engl J Med, 20, 1354
  124. Svedlund, 1983, Psychotherapy in irritable bowel syndrome: a con-trolled outcome study, Acta Psychiatr Scand, 67, 1, 10.1111/j.1600-0447.1983.tb03707.x · DOI
  125. Guthrie, 1991, A controlled trial of psychological treatment for the irritable bowel syndrome, Gastroenterology, 100, 450, 10.1016/0016-5085(91)90215-7 · DOI
  126. Whorwell, 1987, Hypnotherapy in the irritable bowel syndrome, Stress Med, 3, 5, 10.1002/smi.2460030104 · DOI
  127. Talley, 1996, Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials, Am J Gastroenterol, 91, 277
  128. Smart, 1986, Alternative medicine consultations and remedies in patients with irritable bowel syndrome, Gut, 27, 826, 10.1136/gut.27.7.826 · DOI
  129. Mortensen, 1991, Irritable colon and ulcerative colitis. Alternative treatment is used frequently, Ngeskrift Laeger, 153, 3304
  130. Verhoef, 1990, Use of alternative medicine by patients attending a gastroenterology clinic, Can Med Assoc J, 142, 121
  131. Sutherland, 1994, Why do patients seek a second opinion of alternative medicine?, J Clin Gastroenterol, 19, 194, 10.1097/00004836-199410000-00004 · DOI
  132. Bittinger, 1998, Alternative therapy methods in functional disorders of the gastrointestinal system, Z Gastroenterol, 36, 519
  133. Bensoussan, 1998, Treatment of the irritable bowel syndrome with Chinese herbal medicine: a randomised controlled trial, JAMA, 280, 1585, 10.1001/jama.280.18.1585 · DOI · Paper page
  134. Camilleri, 1999, Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5HT3-receptor antagonist, Aliment Pharmacol Ther, 13, 1149, 10.1046/j.1365-2036.1999.00610.x · DOI
  135. Kozlowski, 2000, The 5-HT3 receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat, Gut, 46, 474, 10.1136/gut.46.4.474 · DOI
  136. Viramontes, 2000, Alosetron retards small bowel and overall colonic transit in diarrhea-predominant irritable bowel syndrome (D-IBS) (abstr), Gastroenterology, 118, A848, 10.1016/S0016-5085(00)85534-1 · DOI
  137. Bardhan, 2000, A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome, Aliment Pharmacol Ther, 14, 23, 10.1046/j.1365-2036.2000.00684.x · DOI
  138. Mangel, 1999, Treatment of female IBS patients with alosetron, a potent and selective 5HT3-receptor antagonist (abstr), Gastroenterology, 116, A1036
  139. Camilleri, 2000, Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial, Lancet, 355, 1035, 10.1016/S0140-6736(00)02033-X · DOI
  140. Jones, 1999, Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients, Aliment Pharmacol Ther, 13, 1419, 10.1046/j.1365-2036.1999.00678.x · DOI
  141. Dapoigny, 1995, Efficacy of peripheral kappa agonist, fedotozine, vs. placebo in treatment of irritable bowel syndrome. A multicenter dose-response study, Dig Dis Sci, 40, 2244, 10.1007/BF02209014 · DOI
  142. Grider, 1998, 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine, Gastroenterology, 115, 370, 10.1016/S0016-5085(98)70203-3 · DOI
  143. Nguyen, 1997, SDZ HTF 919 stimulates colonic motility and transit in vivo, J Pharmacol Exp Ther, 280, 1270
  144. Coelho, 2000, Antinociceptive properties of HTF 919 (tegaserod), a 5-HT4 receptor partial agonist, on colorectal distension in rats (abstr), Gastroenterology, 118, A834, 10.1016/S0016-5085(00)85481-5 · DOI
  145. Schikowski, 1999, Dose-dependent modulation of rectal afferent sensitivity by a 5-HT4 receptor agonist (abstr), Gastroenterology, 17, A643
  146. Mueller-Lissner, 2000, Tegaserod, a 5-HT4 receptor partial agonist, relieves key symptoms of irritable bowel syndrome (abstr), Gastroenterology, 118, A175, 10.1016/S0016-5085(00)82778-X · DOI
  147. Briejer, 1997, Serotonin 5-HT4 receptors mediate the R093877-induced changes in contractile patterns in the canine colon (abstr), Gastroenterology, 112, A705
  148. Emmanuel, 1998, Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers, Gut, 42, 511, 10.1136/gut.42.4.511 · DOI
  149. Bouras, 1999, Selective stimulation of colonic transit by the benzofuran 5-HT4 agonist, prucalopride, in healthy humans, Gut, 44, 682, 10.1136/gut.44.5.682 · DOI
  150. Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology (in press). · DOI
  151. Johanson, 2000, Prucalopride improves bowel movement frequency and symptoms in patients with chronic constipation: results of two double-blind, placebo-controlled trials (abstr), Gastroenterology, 118, A175, 10.1016/S0016-5085(00)82777-8 · DOI
  152. Miner, 1999, The efficacy and safety of prucalopride in patients with chronic constipation (abstr), Gastroenterology, 116, A1043
  153. Tack, 1999, A placebo-controlled trial of buspirone, a fundus-relaxing drug, in functional dyspepsia: effect on symptoms and gastric sensory and motor function (abstr), Gastroenterology, 116, A325
  154. Tack, 2000, Influence of citalopram, a selective serotonin reuptake inhibitor, on colonic tone and sensitivity in man (abstr), Gastroenterology, 118, A174, 10.1016/S0016-5085(00)82776-6 · DOI
  155. Malcolm, 2000, Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function, Aliment Pharmacol Ther, 214, 783, 10.1046/j.1365-2036.2000.00757.x · DOI
  156. Malcolm, 1999, Clonidine alters rectal motor and sensory function in irritable bowel syndrome (abstr), Gastroenterology, 116, A1035
  157. Caldarella, 2000, Stimulation of intestinal gas propulsion is the key to treat gas retention in functional patients (abstr), Gastroenterology, 118, 138A, 10.1016/S0016-5085(00)82629-3 · DOI
  158. Kim, 2000, Serotonin: a mediator of brain-gut connection, Am J Gastroenterol, 95, 2698, 10.1111/j.1572-0241.2000.03177.x · DOI

Cited by

Metadata

Authors
Camilleri, M.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2001-02
Volume
120
Issue
3
Pages
652-668
ISSN
0016-5085 (ISSN-L)
DOI
10.1053/gast.2001.21908
OpenAlex
W2043462457
Cited by
343
References
16
FWCI
29.85
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.